Creative Medical Technology Holdings, Inc. (CELZ) - 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Creative Medical Technology Holdings, Inc., a Nevada corporation, on November 12, 2025, covering events occurring on November 6, 2025. The Company's common stock trades on The Nasdaq Stock Market LLC under the symbol "CELZ."
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on executive compensation arrangements.
Material Changes
On November 6, 2025, the Compensation Committee of the Board of Directors approved the following bonus payments:
- Timothy Warbington (Chief Executive Officer): $100,000
- Donald Dickerson (Chief Financial Officer): $25,000
Total approved bonuses amount to $125,000.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to disclose the executive compensation event under Item 5.02.
Investor Verification Checklist
- Verify the source of funds for the $125,000 in approved executive bonuses.
- Review the Company's most recent 10-K or 10-Q filings for context on overall cash position and liquidity.
- Confirm if these bonuses are tied to specific performance metrics or are discretionary.